Scott Macfarlane (oncologist)
From Wikipedia, the free encyclopedia
Sir Scott Macfarlane | |
|---|---|
.jpg) Macfarlane in 2024 | |
| Born | Scott Duncan Macfarlane |
| Alma mater | University of Auckland |
| Occupation | Paediatric oncologist |
Sir Scott Duncan Macfarlane KNZM is a New Zealand paediatric oncologist. Over his career, he was intimately involved in the development of a nationally coordinated approach to child cancer, which saw the survival rate for child cancer in New Zealand improve from 50 percent to better than 80 percent.[1]
Macfarlane studied medicine at the University of Auckland, graduating MB ChB in 1977.[2] He undertook further training in Melbourne, and began his paediatrics career at Waikato Hospital in 1986.[3] Ten years later, he moved to Starship Hospital in Auckland, rising to become clinical director of Starship.[1][3] He was particularly involved in the establishment of the National Child Cancer Network in 2011, heading the body until retiring in November 2021.[1][4]
Macfarlane served as Oceania president of the International Society for Paediatric Oncology and president of the Australia New Zealand Children's Haematology Oncology Group.[1][3] In 2015, he was made a life member of the Child Cancer Foundation.[1]
In the 2024 New Year Honours, Macfarlane was appointed a Knight Companion of the New Zealand Order of Merit, for services to health.[5]